<?xml version="1.0" encoding="UTF-8"?>
<p id="Par12">One therapy, which is giving a positive hope in the current crisis is plasma therapy. In this therapy, the blood is collected from patients who have recovered from COVID-19 and plasma is separated from that. Convalescent plasma which contains antibodies to nCoV is then administered to patients with COVID-19. The use of convalescent plasma has been studied in previous epidemics like the SARS-CoV-1 epidemic, the H1N1 pandemic, and the MERS-CoV epidemic. This treatment has its roots from the first time use of convalescent plasma for the cure of diphtheria in 1901 by Nobel Prize winner (Physiology and Medicine) Emil von Behring. A number of clinical trials with convalescent plasma are going on worldwide with some showing promising results for the prophylaxis of severe cases of COVID-19 (USA Food &amp; Drug Administration 
 <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/media/136470/download" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fda.gov/media/136470/download</ext-link>).
</p>
